21
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8313 |
HCH6-1
|
Others | Others |
HCH6-1 是甲酰肽受体 1 的竞争性二肽拮抗剂。它能够抑制 fMLF (FPR1激动剂) 特异性激活的人中性粒细胞的趋化性、超氧阴离子生成和弹性酶释放。动物实验中,它对急性肺损伤具有保护作用,可用于研究 FPR1 参与的炎症性肺部疾病。 | |||
T6978 |
Almitrine mesylate
Almitrine dimesylate,甲磺酸阿米三嗪,Almitrine bismethanesulfonate,Almitrine bismesylate |
Potassium Channel | Membrane transporter/Ion channel |
Almitrine mesylate (Almitrine dimesylate) 是外周化学感受器激动剂,对Ca2+依赖性的K+通道具有选择性抑制作用。 | |||
T9089 |
FTO-IN-1
UUN44923 |
Others | Others |
UUN44923 是脂肪及肥胖相关酶(FTO) 抑制剂(IC50<1 μM)。其中FTO-IN-1 (UUN44923) 可用于研究癌症。 | |||
T39719 |
Nrf2 activator-1
Nrf2 activator-1 |
Nrf2 | Immunology/Inflammation |
Nrf2 activator-1 是一种有效的 NF-E2 相关因子 2 (Nrf2) 激活剂。Nrf2 activator-1 可用于研究包括哮喘、急性肺损伤 (ALI)、急性呼吸窘迫综合征 (ARDS) 和肺纤维化等 COPD 和其他呼吸系统疾病。 | |||
T25131 |
AZD8309
AZD 8309,AZD-8309 |
Glutathione Peroxidase; CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation; Metabolism |
AZD8309 是一种强效的、可口服的趋化因子受体CXCR2的拮抗剂, 能够调节中性粒细胞的转运,可显著降低胰腺和肺部的MPO,并降低胰腺内的胰蛋白酶和弹性蛋白酶活性。AZD8309 能够用于研究炎症系列疾病。 | |||
T60522 |
Letosteine
Viscotiol |
Others | Others |
Letosteine (Viscotiol) 是具有口服活性、有效且安全的祛痰剂, 可用于研究急性或慢性呼吸道疾病,如支气管肺炎。Letosteine 能够溶解支气管粘液并减轻呼吸道炎症症状,从而实现恢复肺部气体交换和自然防御机制。 | |||
T36454 |
1-Stearoyl-rac-glycerol
|
||
1-Stearoyl-rac-glycerol is a monoacylglycerol that contains stearic acid at the sn-1 position. 1-Stearoyl-rac-glycerol levels are decreased in tumor tissue in a mouse model of azoxymethane-induced colorectal carcinogenesis. Levels of 1-stearoyl-rac-glycerol are decreased in lung tissue from patients with adenocarcinoma, but are increased in the serum of patients with Buruli ulcer and in the cerebrospinal fluid of patients with the inflammatory demyelinating diseases multiple sclerosis (MS), neur... | |||
T29969 |
AMG-126737
105RSZ5CNS,AMG 126737,SCHEMBL7986111 |
||
AMG-126737 is an effective human lung mast cell trypsin inhibitor with potential therapeutic effect in lung diseases. | |||
T15354 |
FTY720 (S)-Phosphate
(S)-FTY720 phosphate,(S)-FTY720P |
Others | Others |
FTY720 (S)-Phosphate is an S1P receptor 1 (S1PR1) agonist. It is used in the research of acute inflammatory diseases such as acute lung injury. | |||
T70616 |
ACT-672125
|
||
ACT-672125 is a Potent CXCR3 Antagonist with Therapeutic Potential in Autoimmune Diseases. ACT-672125 showed good physicochemical properties and safety profile. In a proof-of-mechanism model of lung inflammation, ACT-672125 inhibited the recruitment of CXCR3 expressing T cells into the inflamed lung in a dose-dependent manner. | |||
T21074 |
Dexamethasone acetate
Dexamethasone 21-acetate monohydrate,Decadron-LA,Decadron |
||
Dexamethasone acetate is an adrenocortical steroid. It is used in the treatment of many conditions, including rheumatic problems, a number of skin diseases, asthma, severe allergies, chronic obstructive lung disease, brain swelling, croup, and antibiotics | |||
T78091 |
(S)-FTY720-phosphonate
|
LPL Receptor | GPCR/G Protein |
FTY720 (S)-Phosphate,作为S1P受体1 (S1PR1) 激动剂,可用于研究急性肺损伤等急性炎症。 | |||
T71089 |
PF-00956980
|
||
PF-00956980 是一种可逆的 pan-JAK 抑制剂,作用于 JAK1、JAK2 和JAK3的IC50值分别是 2.2、23.1 和 59.9 μM,可用于肺部和皮肤炎症性疾病研究。 | |||
T76526 |
Ac-D-DGla-LI-Cha-C
|
||
Ac-D-DGla-LI-Cha-C 是一种有效的HCV 蛋白酶抑制剂肽。Ac-D-DGla-LI-Cha-C 可用于癌症、自身免疫性疾病、纤维化疾病、炎症性疾病、神经退行性疾病、感染性疾病、肺部疾病、心脏和血管疾病以及代谢性疾病的研究。 | |||
T63761 | ACT-660602 | ||
ACT-660602 是口服具有活力的趋化因子受体 CXCR3 拮抗剂 (IC50: 204 nM)。ACT-660602 能够抑制 T 细胞迁移,并在体内急性肺损伤模型中显示出显著作用。ACT-660602 能够用于研究自身免疫性疾病。 | |||
T63169 | MIF2-IN-1 | ||
MIF2-IN-1 (compound 5d) 是一种有效的 MIF2 互变异构酶抑制剂 (IC50: 1.0 μM)。MIF2-IN-1 通过 MAPK 通路,阻滞细胞周期,进而抑制非小细胞肺癌细胞的增殖。MIF2-IN-1 具有潜力进行癌症疾病的研究。 | |||
T63809 |
Ansornitinib
|
||
Ansornitinib 是口服具有活力的双激酶抑制剂,能够抑制血小板衍生生长因子受体 (PDGFR) 和血管内皮生长因子受体 (VEGFR2)。Ansornitinib 是一种抗纤维化剂,能够用于研究肺部,肝脏,肾脏以及胃肠等纤维化疾病。 | |||
T63325 |
ATX inhibitor 9
|
||
ATX inhibitor 9 是增稠的杂芳基衍生物化合物,也是 ATX 的有效抑制剂。其中 Autotaxin (ATX),也称为 ENPP2,是一种主要在肺癌细胞、支气管上皮细胞和肺泡巨噬细胞中高度表达的分泌酶。ATX inhibitor 9 对癌症或纤维退行性疾病具有研究潜力。 | |||
T63630 |
Gefitinib dihydrochloride
|
||
Gefitinib dihydrochloride 是有效的、选择性的、口服具有活力的 EGFR 酪氨酸激酶抑制剂 (IC50: 33 nM)。Gefitinib dihydrochloride 能够选择性抑制 EGF 刺激的肿瘤细胞生长,其IC50值为 54 nM,能够阻断 EGF 刺激的肿瘤细胞中EGFR 自磷酸化。Gefitinib dihydrochloride 可以诱导细胞自噬 (autophagy) 和凋亡 (apoptosis),能够用于进行癌症相关疾病,如肺癌和乳腺癌的研究。 | |||
T63183 |
RET-IN-9
|
||
RET-IN-9 是一种 RET 的有效抑制剂。其中 RET 激酶是一种单通道跨膜受体酪氨酸激酶,在肾脏和肠神经系统的发育以及维持神经、内分泌、造血和男性生殖系统的体内平衡中发挥着重要作用。RET-IN-9 具有潜力进行 RET 相关疾病的研究(包括非小细胞肺癌和甲状腺髓样癌)。 | |||
T37631 |
tetranor-12(S)-HETE
|
||
12(S)-HETE is a product of arachidonic acid metabolism through the 12-lipoxygenase pathway. It is primarily found in platelets, leukocytes, and to a lesser extent in smooth muscle cells. It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix. tetranor-12(S)-HETE is the major β-oxidation product resulting from peroxisomal metabolism of 12(S)-HETE in numerous tissues, and Lewis lung carcinoma cells. No biological function has yet been determined for tetran... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5S2347 |
Deoxyshikonin
去氧紫草素,Arnebin 7 |
Others; HIF/HIF Prolyl-Hydroxylase; Antibacterial | Chromatin/Epigenetic; Metabolism; Microbiology/Virology; Others |
Deoxyshikonin (Arnebin 7) 是从紫草中分离的天然产物,具有抗肿瘤活性,在体外具有促血管生成作用。它和没食子酸十二烷基酯在体内外均与青霉素有显着的协同抗菌活性。 |